Leverage the dynamic nature of RNA, combined with our expertise in clinical samples.
Cofactor offers access to two clinically-validated assays to improve your clinical decision making abilities.
Our ImmunoPrism™ assay quantitatively measures 8 key immune cells in solid tumor samples from as little as two FFPE sections.
RNA-seqDx surveys the entire transcriptome to provide a broad look at a patient’s disease state.
Contact us to discuss how we can provide you with the insights you need.
CAP/CLIA-Grade RNA Sequencing Products
|Product Name||Catalog Number||Description||Price per Sample|
|ImmunoPrism™ Clinical Assay||CFGDx-301||Clinically-validated immune characterization for solid tumors||Contact Us|
|RNA-seqDx||CFGDx-101CFGDx-102||Fresh-Frozen CAP/CLIA RNA sequencing, 30 million single-end readsFresh-Frozen CAP/CLIA RNA sequencing, 60 million single-end reads||$1000$1500|
RNA-seqDx includes delivery of FASTQ files only and does not include comparative expression or other advanced analysis.